Clinical Updates: Metastatic Colorectal Cancer
Each of the therapies for mCRC are associated with certain toxicities, many of which differ depending on the mechanism of action; therefore, the supportive care needs of patients receiving systemic therapy for mCRC vary.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Colorectal Cancer
Personalizing treatment selection for each patient with localized colon cancer or metastatic colorectal cancer (mCRC) can maximize the benefits while minimizing the harms to give each patient the best survival and quality of life possible. Clinicians must be knowledgeable about new trial results, new systemic therapy options, new biomarkers, and other treatment-selection criteria in order to help patients make the best informed decisions possible.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation